{"archive_url":"https://www.ebi.ac.uk/ega/datasets/EGAD00001002466","experiment":{"EXPERIMENT_TYPE":"Histone H3K4me3","EXPERIMENT_ID":"EGAX00001326449","attributes":{"EXTRACTION_PROTOCOL_SONICATION_CYCLES":["\"20 min; 30 sec ON/ 30 sec OFF\""],"CHIP_PROTOCOL_BEAD_TYPE":["magnetic beads A and G"],"CHIP_ANTIBODY":["H3K4me3"],"CHIP_PROTOCOL_BEAD_AMOUNT":["20 ul"],"EXPERIMENT_TYPE":["Histone H3K4me3"],"CHIP_ANTIBODY_CATALOG":["pAb-003-050"],"CHIP_PROTOCOL_ANTIBODY_AMOUNT":["1,0 ug"],"CHIP_ANTIBODY_LOT":["A5051-001P"],"CHIP_PROTOCOL_CHROMATIN_AMOUNT":["1x 500.000 cells = 33 ul"],"EXTRACTION_PROTOCOL":["Chromatin was extracted using the histone protocol. Cells are crosslinked at 4 degrees 16 min in 1% formaldehyde. Washed twice in PBS and dissolved in shearing buffer (containing 1% SDS), such that the final concentration is 15*10^6 cells/ml."],"CHIP_PROTOCOL":["Protocol July 2014: 500.000 cells per ChIP. Overnight incubation of chromatin with antibody. 1 hour incubation in the morning with A/G magnetic beads. Wash once with buffer 1, and twice with buffer 2 and 3 at 4 degrees. Elute 20 min with elution buffer at RT. Descrosslink 4 hours at 65 degrees. Purify by column purification."],"LIBRARY_GENERATION_FRAGMENT_SIZE_RANGE":["179"],"CHIP_ANTIBODY_PROVIDER":["Diagenode"],"EXTRACTION_PROTOCOL_TYPE_OF_SONICATOR":["Bioruptor Plus (UCD-300)"]},"ASSAY_TYPE":"ChIP-Seq"},"archive":"EGA","ftp_path":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/B15_50/naive_B_cell/ChIP-Seq/NCMLS","files":[{"FORMAT":"bigBed","SIZE":"867K","NAME":"S0159LH1.ERX1122444.H3K4me3.bwa.GRCh38.20151026.bb","FILE_TYPE":"CHIP_MACS2_BB","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/B15_50/naive_B_cell/ChIP-Seq/NCMLS/S0159LH1.ERX1122444.H3K4me3.bwa.GRCh38.20151026.bb","PROTOCOL_DOC":"chip_seq_grch38","MD5":"758105ee9ed97d0670fac2b096d339fc"},{"FORMAT":"BED","SIZE":"957K","NAME":"S0159LH1.ERX1122444.H3K4me3.bwa.GRCh38.20151026.bed.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/B15_50/naive_B_cell/ChIP-Seq/NCMLS/S0159LH1.ERX1122444.H3K4me3.bwa.GRCh38.20151026.bed.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"924187a7c7a8440f4fdc105c9041d295"},{"FORMAT":"Text","SIZE":"1.1M","NAME":"S0159LH1.ERX1122444.H3K4me3.bwa.GRCh38.20151026.xls.gz","FILE_TYPE":"CHIP_MACS2_BED","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Enriched regions","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/B15_50/naive_B_cell/ChIP-Seq/NCMLS/S0159LH1.ERX1122444.H3K4me3.bwa.GRCh38.20151026.xls.gz","PROTOCOL_DOC":"chip_seq_grch38","MD5":"cc801c805d48d178d4000b2af676160e"},{"FORMAT":"bigWig","SIZE":"695M","NAME":"S0159LH1.ERX1122444.H3K4me3.bwa.GRCh38.20151029.bw","FILE_TYPE":"CHIP_WIGGLER","ANALYSIS_GROUP":"EMBL-EBI","TYPE":"Normalized signal","PATH":"http://ftp.ebi.ac.uk/pub/databases/blueprint/data/homo_sapiens/GRCh38/venous_blood/B15_50/naive_B_cell/ChIP-Seq/NCMLS/S0159LH1.ERX1122444.H3K4me3.bwa.GRCh38.20151029.bw","PROTOCOL_DOC":"chip_seq_grch38","MD5":"1b7f9503e7b5ba5ed0474849c25c9b58"}],"dataset_id":"EGAD00001002466","sample":{"SAMPLE_SOURCE":"venous blood","SAMPLE_NAME":"B15_50","sample_barcode":"S0159LH1","attributes":{"DISEASE":["None"],"TREATMENT":["NA"],"CELL_TYPE":["naive B cell"],"DISEASE_ONTOLOGY_URI":["NA"],"SAMPLE_ONTOLOGY_URI":[{"url":"8","label":"CL_0000788"}],"GENDER":["female"],"DONOR_ID":["B15_50"],"PASSAGE_IF_EXPANDED":["NA"],"MARKERS":["CD19+,CD27-,IgD+"],"DONOR_HEALTH_STATUS":["Healthy"],"MOLECULE":["genomic DNA"],"DONOR_AGE":["55 - 60"],"BIOMATERIAL_PROVIDER":["Jose I. Martin-Subero"],"TISSUE_TYPE":["venous blood"],"BIOMATERIAL_TYPE":["Primary Cell"],"DONOR_SEX":["Female"],"DONOR_ETHNICITY":["NA"]},"SAMPLE_ID":"EGAN00001277492","SAMPLE_DESCRIPTION":"naive B cell"}}